For children battling both congenital heart defects (CHD) and cancer, the road to recovery is far more precarious than previously...

Findings from scientists at St. Jude Children's Research Hospital are showing promise for assessing cardiomyopathy risk in childhood...

The link is not uncommon: ‘Cardiotoxicity’ is a major side effect of anticancer treatments. Read more: https://www.washingtonpost.com/wel...

Although more than 85% of childhood cancer survivors will achieve a 5-year survival, that does not tell the whole tale for these...

New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood...

In a U.S./Canadian phase IIb trial (PREVENT-HF) reported in The Lancet Oncology, Armenian et al found that the beta-blocker carvedilol...

In survivors of childhood cancer, recent research has found that two common biomarkers may be able to predict heart risk, according to a...

Results suggest that more childhood cancer survivors may benefit from a heart-saving medication called carvedilol, even long after their...

Adult survivors of childhood cancer with a high risk of cardiovascular disease may not be receiving proper cardiac testing, according to...

In a collaborative study between Fred Hutchinson Cancer Center and the University of Minnesota, Dr. Baker along with Dr. Tyler Ketterl,...